P D Marsh Selected Research

Infections

12/2016	Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
5/2012	The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge.
3/2006	Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection.
1/2004	Minimizing prion risk without compromising the microbial composition of biofilms grown in vivo in a human plaque model.
12/2000	Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
4/2000	The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P D Marsh Research Topics

Disease

7	Tuberculosis (Tuberculoses) 01/2017 - 12/2000
6	Infections 12/2016 - 04/2000
4	Periodontal Diseases (Periodontal Disease) 01/2022 - 01/2004
3	Dysbiosis 01/2022 - 12/2017
3	Dental Plaque 01/2005 - 01/2003
2	Periodontitis 01/2022 - 01/2020
2	Dental Caries (Decay, Dental) 12/2017 - 02/2003
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2008 - 10/2007
2	Hypersensitivity (Allergy) 06/2001 - 12/2000
1	Halitosis 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Root Caries 01/2021
1	Xerostomia 01/2021
1	Inflammation (Inflammations) 01/2018
1	Lung Diseases (Lung Disease) 05/2013
1	Disease Progression 11/2009
1	Poliomyelitis (Polio) 12/2007
1	Wounds and Injuries (Trauma) 10/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2006
1	Gingivitis 01/2004
1	Periodontal Pocket (Periodontal Pockets) 11/2000

Drug/Important Bio-Agent (IBA)

6	AerosolsIBA 01/2017 - 04/2000
5	VaccinesIBA 12/2016 - 11/2009
3	AcidsIBA 01/2022 - 02/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 03/2006
2	NitratesIBA 01/2022 - 01/2022
2	SugarsIBA 01/2021 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2007
2	ToothpastesIBA 01/2017 - 01/2004
2	AntigensIBA 05/2013 - 03/2006
2	Tuberculin (PPD)IBA 06/2001 - 12/2000
1	NitritesIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Free RadicalsIBA 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2021
1	Durapatite (Hydroxylapatite)IBA 01/2020
1	CarbohydratesIBA 01/2018
1	PrebioticsIBA 01/2018
1	EnzymesIBA 01/2017
1	MVA 85AIBA 05/2013
1	CytokinesIBA 10/2012
1	InterferonsIBA 10/2012
1	Ferritins (Ferritin)IBA 05/2012
1	LactoferrinIBA 05/2012
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2012
1	Messenger RNA (mRNA)IBA 05/2012
1	IronIBA 05/2012
1	Formaldehyde (Formol)FDA Link 11/2009
1	SuspensionsIBA 12/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006
1	alpha-Crystallins (alpha-Crystallin)IBA 03/2006
1	Immunoglobulin A (IgA)IBA 03/2006
1	Anti-Infective Agents (Microbicides)IBA 01/2005
1	Hypochlorous Acid (Hypochlorite)IBA 01/2004
1	PrionsIBA 01/2004
1	Triclosan (pHisoHex)FDA Link 01/2004
1	PolymersIBA 01/2003
1	iron protoporphyrin IXIBA 11/2000

Therapy/Procedure

1	Transplantation 06/2008
1	Punctures 10/2007
1	Dental Instruments 10/2007
1	Drug Therapy (Chemotherapy) 03/2006